Presentation is loading. Please wait.

Presentation is loading. Please wait.

The information contained in this presentation shall not be shared or furnished without prior written consent by Hyundai Pharm.

Similar presentations


Presentation on theme: "The information contained in this presentation shall not be shared or furnished without prior written consent by Hyundai Pharm."— Presentation transcript:

1 The information contained in this presentation shall not be shared or furnished without prior written consent by Hyundai Pharm

2

3 This is the mark given by the government for selected innovative companies

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18 CATERIA PRODUCTSACTIONINDICATIONDEVELOPMENT STATUS AripiprazoleIRAntipsychotics Acute manic and mixed episodes associated with bipolar disorder Launch ready (expected in Feb, 2014) Donepezil HClSRAnticholinesterases Dementia from Alzheimer’s disease Finished the formulation study Levetiracetam SR AntiepilepticsEpilepsy Finished the formulation study IR Launch ready (expected in Jan, 2013) MirtazapineIRTCADepression Launch ready (expected in Dec, 2012) Pramipexole HCl SR Dopamine agonistsParkinson’s Disease Launch ready (expected in May, 2013) IRBE ready Choline alfoscerate SR ParasympathomimeticCognitive disorder Phase I ready IRBE ready LacosamideSR voltage-gated sodium channels epilepsyPre Clinical Fentanyl citrate trans mucosal Phenylpiperidine derivative Narcotic analgesicIn fomulation Study Acebrophylline SR Muco-activeRespiratory diseasePhase I Levodropropizine SR peripheral antitussiveCoughLaunch ready Oncology Imatinib mesylate Mini-tablet tyrosine kinase inhibitor chronic myelogenous leukemia In fomulation Study

19 CATERIA PRODUCTSACTIONINDICATIONDEVELOPMENT STATUS IbandronateIRBisphosphonateOsteoporosisLaunched in August, 2012 Telmisartan + HCTZCOM Angiotensin II antagonist HypertensionFinished the formulation study Valsartan + AmlodipineCOM Angiotensin II antagonist Hypertension Launch Ready (In process of product approval) TamsulosinCR / OD Alpha adrenoreceptor antagonist BPHBE Ready DutasterideWeekly 5-alpha-reductase inhibitor AlopeciaPre Clinical Ecabet + RanitidineCOM Antiulcerant Mucosal protection Gastroduodenal Ulcer Pre Clinical EsomeprazoleODproton pump inhibitor gastro esophageal reflux disease In fomulation Study Clindamycin+AdapaleneCOMantibiotic+retinoid Mild to moderate acne Pre Clinical HOB-060Topical Synthetic derivative of the amino acid WhiteningIn fomulation Study


Download ppt "The information contained in this presentation shall not be shared or furnished without prior written consent by Hyundai Pharm."

Similar presentations


Ads by Google